'FDA's Call For New Authorities Over Hemp Derived Cannabinoid Products' Begins At Cannabis Capital Conference
Portfolio Pulse from Benzinga Newsdesk
The FDA has called for new authorities over hemp-derived cannabinoid products at the Cannabis Capital Conference. The news was reported by Benzinga, a financial news outlet.
September 28, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The FDA's call for new authorities over hemp-derived cannabinoid products may impact the AdvisorShares Pure US Cannabis ETF (MSOS).
The FDA's call for new authorities over hemp-derived cannabinoid products could potentially lead to stricter regulations in the cannabis industry. This could impact the performance of the AdvisorShares Pure US Cannabis ETF (MSOS), which invests in US companies involved in the legal cannabis industry.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80